Biotechnology Buyers & Acquisitions in Ohio

Tracked deals

6

6 tracked deals across 2020-2026.

Buyer mix

Strategic-led

7 strategic · 1 pe

Top trend

Volume peaked in 2023

2 tracked deals announced in 2023.

Buyer Snapshot

Top Buyers

Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.

Build a buyer list for your Biotechnology deal →
Buyer # Deals Focus Type
Calibre Scientific 2 Diversified global provider of life‑science reagents, too... Strategic
Ajinomoto Co., Inc. 1 Global food and bioscience company with a Bio-Pharma Serv... Strategic
Edgewater Capital Partners 1 Sector-focused private equity firm investing in middle-ma... PE
Eurofins Clinical Testing US Holdings, Inc. 1 US subsidiary entity of Eurofins focused on clinical test... Strategic
Eurofins Scientific 1 Global bioanalytical and laboratory testing services prov... Strategic
VION Biosciences 1 Life sciences tools and services company building integra... Strategic
Vector Laboratories 1 Developer and manufacturer of proteomic, glycomic and bio... Strategic

Acquisition Volume in Biotechnology in Ohio by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for Biotechnology Buyers & Acquisitions in Ohio. 1 2020 1 2021 2 2023 1 2024 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • VION Biosciences Acquires Prolytix
    September 8, 2026
    Buyer
    VION Biosciences, Edgewater Capital Partners
    Target
    Prolytix
    Seller
    Edgewater Capital Partners
    Industry
    Biotechnology
    Location
    Ohio, United States
    Type
    Buyout

    VION Biosciences announced the closing of its acquisition of Prolytix, a provider of regulated bioanalytical and CMC services, research reagents, and custom sample collection products. The deal is intended to strengthen VION’s integrated platform across biopharma services and diagnostic workflow inputs, including regulated large-molecule testing and workflow-critical reagents and IVD materials.

  • Calibre Scientific Acquires Molecular Research Center (MRC)
    October 7, 2024
    Buyer
    Calibre Scientific
    Target
    Molecular Research Center, Inc.
    Industry
    Biotechnology
    Location
    Ohio, United States
    Type
    Buyout

    Calibre Scientific has acquired Molecular Research Center, Inc. (MRC), an Ohio-based developer and manufacturer of reagents and kits for RNA and DNA isolation and analysis. The acquisition expands Calibre Scientific's life‑science reagent and molecular biology product offering and strengthens its capabilities in nucleic acid isolation technologies.

  • Ajinomoto Co., Inc. Acquires Forge Biologics
    November 13, 2023
    Buyer
    Ajinomoto Co., Inc.
    Target
    Forge Biologics
    Seller
    Forge unitholders
    Industry
    Biotechnology
    Location
    Ohio, United States
    Type
    Buyout

    Ajinomoto Co., Inc. will acquire Forge Biologics in an all-cash transaction valued at $620 million, expanding Ajinomoto's gene therapy and plasmid/AAV manufacturing capabilities. Forge, a Columbus, Ohio–based viral vector and plasmid CDMO with a 200,000 sq ft cGMP facility and ~300+ employees, will become a consolidated subsidiary to accelerate global gene and cell therapy manufacturing capacity.

  • Vector Laboratories Acquires Quanta BioDesign
    June 17, 2023
    Buyer
    Vector Laboratories
    Target
    Quanta BioDesign
    Industry
    Biotechnology
    Location
    Ohio, United States
    Type
    Buyout

    Vector Laboratories has acquired Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG) technology, expanding Vector's bioconjugation linkers, dyes and payload delivery capabilities. The Plain City, Ohio-based company's dPEG reagents will broaden Vector's product portfolio and support life science and biopharma customers in therapeutic, diagnostic and research applications.

  • Eurofins to Acquire DNA Diagnostics Center (DDC) to Expand Consumer Genetic Testing
    June 28, 2021
    Buyer
    Eurofins Scientific, Eurofins Clinical Testing US Holdings, Inc.
    Target
    DNA Diagnostics Center (DDC)
    Seller
    GHO Capital Partners LLP (GHO Capital)
    Industry
    Biotechnology
    Location
    Ohio, United States
    Type
    Buyout

    Eurofins Scientific, via its subsidiary Eurofins Clinical Testing US Holdings, has entered into an agreement to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing laboratory. The deal is expected to expand Eurofins’ reach into consumer genetics and health & wellness markets, with DDC projected to generate over $55M in 2021 revenue and operating from its Fairfield, Ohio facility.

  • Calibre Scientific Acquires NeXtal Biotechnologies from Qiagen
    January 8, 2020
    Buyer
    Calibre Scientific
    Target
    NeXtal Biotechnologies
    Seller
    Qiagen NV
    Industry
    Biotechnology
    Location
    Ohio, United States
    Type
    Divestiture

    Calibre Scientific has acquired the NeXtal Biotechnologies line of structural biology products (including EasyXtal crystallization plates) from Qiagen NV. The purchase expands Calibre's structural biology and protein crystallization product portfolio, supplying academic, biotechnology, and pharmaceutical customers.

Build a buyer list for your Biotechnology deal

Find buyers actively acquiring biotechnology companies.

Apply as a Buyer

Related Acquisition Pages

Biotechnology Buyers & Acquisitions Biotechnology Buyers & Acquisitions in Canada Private Equity-Backed Biotechnology Buyers Biotechnology Acquisitions in 2026 Biotechnology Acquisitions in 2024 Biotechnology Acquisitions in 2023 Biotechnology Acquisitions in 2021 Biotechnology Acquisitions in 2020 Acquisitions in Ohio Private Equity-Backed Acquisitions in Ohio Acquisitions in Ohio in 2026 Acquisitions in Ohio in 2024

Related articles